ARCHIVES

FDA Approves Rituxan For NHL With CHOP Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 2 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Tracor Could Earn $186,000 As Prime Contractor On Carcinogenesis Bioassay

April 26, 1974

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

July 22, 2011

Turmoil in Texas: Texas Agency Funded $11 Million Grant Without Peer Review; Official Resigns

November 30, 2012

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

September 16, 2005

DeVita Accepts “Chop Lie” Cancer Control Elements In CCOP; RFA Delays Until After May NCAB Meeting

March 12, 1982

NCI CTEP Approved Trials For the Month of April

April 26, 2013